Meniere's disease: Difference between revisions

(Text replacement - " prednisone" to " prednisone")
Line 26: Line 26:


==Management==
==Management==
*Treat vertigo symptomatically with scopolamine, antihistamines, or benzodiazepines
*Treat vertigo symptomatically with [[scopolamine]], [[antihistamines]], or [[benzodiazepines]]
*Vestibulosuppressant options<ref>Minor LB, Schessel DA, Carey JP. Ménière's disease. Curr Opin Neurol. 2004 Feb. 17(1):9-16.</ref>
*Vestibulosuppressant options<ref>Minor LB, Schessel DA, Carey JP. Ménière's disease. Curr Opin Neurol. 2004 Feb. 17(1):9-16.</ref>
**Meclizine 25-50mg PO
**[[Meclizine]] 25-50mg PO
**Diazepam 5-10mg PO or IV
**[[Diazepam]] 5-10mg PO or IV
**Other options: scopolamine, promethazine, prochlorperazine, metoclopramide
**Other options: [[scopolamine]], [[promethazine]], [[prochlorperazine]], [[metoclopramide]]
*Diuretics may decrease fluid pressure in ear:
*[[Diuretics]] may decrease fluid pressure in ear:
**HCTZ
**[[Hydrochlorothiazide]]
**Acetazolamide
**[[Acetazolamide]]
**Avoid loop diuretics due to ototoxicity
**Avoid loop diuretics due to ototoxicity
*Consider IM steroid injection, followed by tapered PO [[prednisone]]<ref>Sajjadi H. Medical management of Meniere's disease. Otolaryngol Clin North Am. 2002 Jun. 35(3):581-9, vii.</ref>
*Consider IM steroid injection, followed by tapered PO [[prednisone]]<ref>Sajjadi H. Medical management of Meniere's disease. Otolaryngol Clin North Am. 2002 Jun. 35(3):581-9, vii.</ref>

Revision as of 15:20, 3 April 2017

Background

  • Occurs due to increased endolymph within the cochlea and labyrinth
  • First attack usually occurs in patients >65yrs
  • Usually is unilateral but may become bilateral with time

Clinical Features

  • Episodes of sudden-onset vertigo with nausea/vomiting
    • Duration: usually 2-8hr
    • Frequency: Ranges from several episodes per week to several times per month
  • Roaring tinnitus
  • Diminished hearing
  • Fullness in affected ear
  • Between attacks patient is well (although decreased hearing may persist)

Differential Diagnosis

Vertigo

Evaluation

Management

Disposition

  • Refer to ENT

References

  1. Lorenzi MC, Bento RF, Daniel MM, Leite CC. Magnetic resonance imaging of the temporal bone in patients with Ménière's disease. Acta Otolaryngol. 2000 Aug. 120(5):615-9.
  2. Minor LB, Schessel DA, Carey JP. Ménière's disease. Curr Opin Neurol. 2004 Feb. 17(1):9-16.
  3. Sajjadi H. Medical management of Meniere's disease. Otolaryngol Clin North Am. 2002 Jun. 35(3):581-9, vii.
  4. Pullens B, Giard JL, Verschuur HP, van Benthem PP. Surgery for Ménière's disease. Cochrane Database Syst Rev. 2010 Jan 20. CD005395.
  5. Barrs DM. Intratympanic corticosteroids for Meniere's disease and vertigo. Otolaryngol Clin North Am. 2004 Oct. 37(5):955-72, v.